Study Stopped
Manufacturer decided not to proceed with study.
MDR-JuggerKnot Mini Soft Anchor in Maxillofacial TMJ
Post-market Clinical Follow-Up Study to Collect Safety, Performance and Clinical Benefits Data of the JuggerKnot Mini Soft Anchor for Use in the Maxillofacial Treatment of Temporomandibular Joint (TMJ)
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The objective of this retrospective consecutive series PMCF study is to collect data confirming safety, performance and clinical benefits of the JuggerKnot Mini Soft Anchor (implant and instrumentation) when used for soft tissue to bone fixation in the treatment of temporomandibular joint (TMJ) surgery. Safety, performance, and clinical benefits will be evaluated at the following time points: pre op, 6 weeks, 3 months and 1-year follow-up. JuggerKnot Mini has been on the market since November of 2011.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedJanuary 27, 2022
January 1, 2022
10 months
July 18, 2019
January 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Device Safety Assessed Through the Incidence and Frequency of Revisions, Complications, and Adverse Events
Assessment of safety by recording and analyzing the incidence and frequency of revisions, complications, and adverse events.
Out to a minimum of 1 year
Secondary Outcomes (3)
Device performance and Clinical Benefits Assessed by a Pain Assessment. and Temporomandibular Joint Function of the Pain Assessment Survey Case Report Form.
Out to a minimum of 1 year
Device performance and Clinical Benefits Assessed by a TMJ Function Pain Assessment Survey Case Report Form
Out to a minimum of 1 year
Device performance and Clinical Benefits Assessed by a Headache Pain Assessment Survey Case Report Form
Out to a minimum of 1 year
Study Arms (1)
JuggerKnot Mini Soft Anchors
Patients who have been implanted with the JuggerKnot Mini Soft Anchor who have undergone repair, repositioning or reattachment of soft tissues, ligament and tendons to the mandible is require for surgical stabilization of the TMJ articular disc
Interventions
Patient who have been implanted with one or more JuggerKnot Mini Soft Anchor(s) who have undergone repair, repositioning or reattachment of soft tissues, ligament and tendons to the mandible is require for surgical stabilization of the TMJ articular disc.
Eligibility Criteria
Consecutive series of subjects implanted with one or more JuggerKnot Mini Soft Anchors in the treatment of temporomandibular joint (TMJ) disease according to the approved indications for 93 total joints. Inclusion/exclusion criteria mirror the indications and contraindications in the IFU.
You may qualify if:
- Implanted with one or more JuggerKnot Mini Soft Anchor(s) with either a 2-0 or 3-0 suture
- Must have undergone repair, repositioning or reattachment of soft tissues, ligament and tendons to the mandible is required for surgical stabilization of the TMJ articular disc
You may not qualify if:
- Local Infection.
- Patient conditions including blood supply limitations and insufficient quantity or quality off bone or soft tissue.
- Patients with mental or neurological conditions who are unwilling or incapable of following postoperative care instructions or patients who are otherwise unwilling or incapable of doing so.
- Foreign body sensitivity where material sensitivity is suspected.
- Off-label use.
- Sepsis.
- Patient is a prisoner.
- Patient is a known alcohol or drug abuser.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kacy Arnold
Zimmer Biomet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2019
First Posted
July 26, 2019
Study Start
December 1, 2021
Primary Completion
October 1, 2022
Study Completion
November 1, 2022
Last Updated
January 27, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share